The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
A phase Ib multicohort study of MK-3475 in patients with advanced solid tumors.
Rita Nanda
No relevant relationships to disclose
Elizabeth R. Plimack
Research Funding - Merck
Elizabeth Claire Dees
No relevant relationships to disclose
Shilpa Gupta
No relevant relationships to disclose
Raanan Berger
No relevant relationships to disclose
Aymen Elfiky
No relevant relationships to disclose
Lajos Pusztai
Consultant or Advisory Role - Merck
Research Funding - Merck
Laurence Buisseret
No relevant relationships to disclose
Ravit Geva
No relevant relationships to disclose
Sara I Pai
Consultant or Advisory Role - Merck
Kumudu Pathiraja
Employment or Leadership Position - Merck
Robert Iannone
Employment or Leadership Position - Merck
Stock Ownership - Merck
Christine Gause
Employment or Leadership Position - Merck
Holly Brown
Employment or Leadership Position - Merck
Jennifer Houp
Employment or Leadership Position - Merck
Jonathan D. Cheng
Employment or Leadership Position - Merck
Stock Ownership - Merck
Research Funding - Merck
Laura Quan Man Chow
No relevant relationships to disclose